Citations

Clear

623 citation(s) found for "Torres, V".

Imatinib in Pulmonary Arterial Hypertension: C‐Kit Inhibition
Farha, Samar , Dweik, Raed A. , Rahaghi, Franck , Benza, Raymond L. , Frantz, Robert P. , Torres, Fernando , Quinn, Deborah A., Comhair, Suzy, Erzurum, Serpil C. , Asosingh, Kewal, Frantz, Robert, Benza, Raymond L. , Hassoun, Paul M. , Frantz, Robert P

Mayo Clinic

Pulmonary Circulation | July 24, 2014 | Volume: 4 | Issue: 3 | Pages: 452-455

10.1086/677359 | PMID 25621158 Get It

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by severe remodeling of the pulmonary artery resulting in increased pulmonary artery pressure and right ventricular hypertrophy and, ultimately, failure. Bone marrow–derived progenitor cells play a critical role in vascular homeostasis and have been shown to be involved in the pathogenesis of PAH. A proliferation of c‐Kit+ hematopoietic progenitors and mast cells has been noted in the remodeled vessels in PAH. Imatinib, a tyrosine kinase inhibitor that targets c‐Kit, has been shown to be beneficial for patients with PAH. Here we hypothesize that the clinical benefit of imatinib in PAH could be related to c‐Kit inhibition of progenitor cell mobilization and maturation into mast cells. As a corollary to the phase 3 study using imatinib in PAH, blood samples were collected from 12 patients prior to starting study drug (baseline) and while on treatment at weeks 4 and 24. Eight were randomized to imatinib and 4 to placebo. Circulating c‐Kit+ and CD34+ CD133+ hematopoietic progenitors as well as biomarkers of mast cell numbers and activation were measured. Circulating CD34+ CD133+ and c‐Kit+ progenitor cells as well as c‐Kit+/CD34+ CD133+ decreased with imatinib therapy (all P < 0.05). In addition, total tryptase, a marker of mast cell load, dropped with imatinib therapy (P = 0.02) and was related to pulmonary vascular resistance (R = 0.7, P = 0.02). The findings support c‐Kit inhibition as a potential mechanism of action of imatinib in PAH and suggest that tryptase is a potential biomarker of response to therapy.
Microbial Population Dynamics in the Hemolymph of Manduca sexta Infected with Xenorhabdus nematophila and the Entomopathogenic Nematode Steinernema carpocapsae
Reese, Jordan , Casanova‐Torres, Ángel M., Goodrich‐Blair, Heidi , Forst, Steven , Reese, Jordan M, Singh, Swati

Mayo Clinic

Applied and Environmental Microbiology | May 10, 2014 | Volume: 80 | Issue: 14 | Pages: 4277-4285

10.1128/aem.00768-14 | PMID 24814780 Get It

ABSTRACT Xenorhabdus nematophila engages in a mutualistic association with the nematode Steinernema carpocapsae . The nematode invades and traverses the gut of susceptible insects. X. nematophila is released in the insect blood (hemolymph), where it suppresses host immune responses and functions as a pathogen. X. nematophila produces diverse antimicrobials in laboratory cultures. The natural competitors that X. nematophila encounters in the hemolymph and the role of antimicrobials in interspecies competition in the host are poorly understood. We show that gut microbes translocate into the hemolymph when the nematode penetrates the insect intestine. During natural infection, Staphylococcus saprophyticus was initially present and subsequently disappeared from the hemolymph, while Enterococcus faecalis proliferated. S. saprophyticus was sensitive to X. nematophila antibiotics and was eliminated from the hemolymph when coinjected with X. nematophila . In contrast, E. faecalis was relatively resistant to X. nematophila antibiotics. When injected by itself, E. faecalis persisted (∼10 3 CFU/ml), but when coinjected with X. nematophila , it proliferated to ∼10 9 CFU/ml. Injection of E. faecalis into the insect caused the upregulation of an insect antimicrobial peptide, while the transcript levels were suppressed when E. faecalis was coinjected with X. nematophila . Its relative antibiotic resistance together with suppression of the host immune system by X. nematophila may account for the growth of E. faecalis . At higher injected levels (10 6 CFU/insect), E. faecalis could kill insects, suggesting that it may contribute to virulence in an X. nematophila infection. These findings provide new insights into the competitive events that occur early in infection after S. carpocapsae invades the host hemocoel.
Non‐invasive isometric force measurement of plantar flexors in rats
Chawla, Aditya , Spinner, Robert J. , Lizardi, Michael Torres , Yaszemski, Michael J. , Windebank, Anthony J. , Wang, Huan

Mayo Clinic

Muscle & Nerve | February 24, 2014 | Volume: 50 | Issue: 5 | Pages: 812-821

10.1002/mus.24219 | PMID 24639363 Get It

ABSTRACTIntroduction: Isometric muscle force measurement is a sensitive marker for motor function recovery in rat nerve repair models. Current methods of eliciting maximal isometric force with nerve stimulation cannot provide longitudinal data.Methods: We developed a novel method for measuring isometric muscle force with a device designed to allow minimally invasive nerve stimulation and measurement of plantar flexion force. This indirectly elicited muscle force was compared with muscle force elicited by direct muscle stimulation in 3 surgical models.Results: The force measured after sciatic nerve transection and repair followed a parabolic trend. There was a postinjury decrease in force that continued until postoperative day 42, after which the force increased with time, indicating muscle reinnervation.Conclusions: This approach can track longitudinal changes in force in the most common animal model for studies of clinically relevant problems in the peripheral nerve field.Muscle Nerve50: 812–821, 2014
Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD
Vijayakumar, Soundarapandian, Dang, Suparna, Marinkovich, M. Peter , Lazarova, Zelmira, Yoder, Bradley K. , Wallace, Darren P. , Torres, Vicente E. , Wallace, Darren P , Yoder, Bradley K

Mayo Clinic

American Journal of Physiology-Renal Physiology | December 27, 2013 | Volume: 306 | Issue: 6 | Pages: F640-F654

10.1152/ajprenal.00104.2013 | PMID 24370592 Get It

Basement membrane abnormalities have often been observed in kidney cysts of polycystic kidney disease (PKD) patients and animal models. There is an abnormal deposition of extracellular matrix molecules, including laminin-α3,β3,γ2 (laminin-332), in human autosomal dominant PKD (ADPKD). Knockdown of PKD1 paralogs in zebrafish leads to dysregulated synthesis of the extracellular matrix, suggesting that altered basement membrane assembly may be a primary defect in ADPKD. In this study, we demonstrate that laminin-332 is aberrantly expressed in cysts and precystic tubules of human autosomal recessive PKD (ARPKD) kidneys as well as in the kidneys of PCK rats, an orthologous ARPKD model. There was aberrant expression of laminin-γ2 as early as postnatal day 2 and elevated laminin-332 protein in postnatal day 30, coinciding with the formation and early growth of renal cysts in PCK rat kidneys. We also show that a kidney cell line derived from Oak Ridge polycystic kidney mice, another model of ARPKD, exhibited abnormal lumen-deficient and multilumen structures in Matrigel culture. These cells had increased proliferation rates and altered expression levels of laminin-332 compared with their rescued counterparts. A function-blocking polyclonal antibody to laminin-332 significantly inhibited their abnormal proliferation rates and rescued their aberrant phenotype in Matrigel culture. Furthermore, abnormal laminin-332 expression in cysts originating from collecting ducts and proximal tubules as well as in precystic tubules was observed in a human end-stage ADPKD kidney. Our results suggest that abnormal expression of laminin-332 contributes to the aberrant proliferation of cyst epithelial cells and cyst growth in genetic forms of PKD.
Evaluating health‐related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume
Wijnands, Titus F. M., Neijenhuis, Myrte K., Kievit, Wietske , Nevens, Frederik , Hogan, Marie C. , Drenth, Joost P.H. , Torres, Vicente E. , Gevers, Tom J.G. , Hogan, Marie C , Drenth, Joost P H

Mayo Clinic

Liver International | December 9, 2013 | Volume: 34 | Issue: 10 | Pages: 1578-1583

10.1111/liv.12430 | PMID 24313956 Get It

AbstractBackground & AimsPolycystic liver disease (PLD) follows a progressive course ultimately leading to severe hepatomegaly and mechanical complaints in a subset of patients. It is still unknown to what extent this compromises health‐related quality of life (HRQL). Our aim was to determine HRQL in PLD patients and investigate its association with concurrent abdominal symptoms and liver volume.MethodsPooled data of 92 severe PLD patients from two randomized clinical trials were used for our cross‐sectional analysis. HRQL was assessed using the generic short‐form health survey (SF‐36) resulting in eight scale scores and the summarizing physical (PCS) and mental component score (MCS). Subsequently, these were compared with the general population. Abdominal symptoms were measured with a standardized, 7‐point scale questionnaire in 54 patients. We dichotomized symptoms for absence or presence and compared them with the component scores. Finally, a possible correlation between liver volume and HRQL was explored.ResultsDemographics showed severe polycystic livers (mean 4906 ± 2315 ml). PCS was significantly lower compared with the general population (P < 0.001), in contrast with a similar MCS (P = 0.82). PLD patients had statistically significant (P < 0.05) diminished physical functioning, role physical, general health, vitality and social functioning scores. Upper‐ and lower abdominal pain and dyspnoea were significantly associated with a reduced PCS (P < 0.01). No correlation was found between liver volume and HRQL.ConclusionPolycystic liver disease patients had significantly lower HRQL in the physical dimension compared with the general population. Abdominal pain and dyspnoea had a significant impact on this physical dimension of HRQL.
Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength
Randall, Connor, Bridges, Daniel , Nogués, Xavier , Torres, Elisa, Mellibovsky, Leonardo , Hoffseth, Kevin , Stalbaum, Tyler, Srikanth, Ananya, Weaver, James C. , Rosen, Sasha, Barnard, H. R. , Brimer, Davis, Proctor, Alex, Candy, James V., Saldaña, Christopher , Chandrasekar, Srinivasan , Lescun, Timothy B. , Nielson, Carrie M. , Herthel, D. J., Kopeikin, Hal, Yang, Henry T. Y., McCready, Louise K., Khosla, Sundeep , Hansma, Paul K. , Güerri‐Fernández, Robert , Puig, Lluís , Orwoll, Eric , Farr, Joshua N. , Díez‐Pérez, Adolfo , Khosla, Sundeep

Mayo Clinic

Journal of Medical Devices | September 24, 2013 | Volume: 7 | Issue: 4 | Pages: No page available

10.1115/1.4024829 | PMID 24115973 Get It

A novel, hand-held Reference Point Indentation (RPI) instrument, measures how well the bone of living patients and large animals resists indentation. The results presented here are reported in terms of Bone Material Strength, which is a normalized measure of how well the bone resists indentation, and is inversely related to the indentation distance into the bone. We present examples of the instrument's use in: (1) laboratory experiments on bone, including experiments through a layer of soft tissue, (2) three human clinical trials, two ongoing in Barcelona and at the Mayo Clinic, and one completed in Portland, OR, and (3) two ongoing horse clinical trials, one at Purdue University and another at Alamo Pintado Stables in California. The instrument is capable of measuring consistent values when testing through soft tissue such as skin and periosteum, and does so handheld, an improvement over previous Reference Point Indentation instruments. Measurements conducted on horses showed reproducible results when testing the horse through tissue or on bare bone. In the human clinical trials, reasonable and consistent values were obtained, suggesting the Osteoprobe® is capable of measuring Bone Material Strength in vivo, but larger studies are needed to determine the efficacy of the instrument's use in medical diagnosis.
Targeting Pancreatic Cancer with Magneto-Fluorescent Theranostic Gold Nanoshells
Chen, Wenxue , Ayala‐Orozco, Ciceron , Pérez‐Torres, Carlos J. , Bartels, Marc, Bardhan, Rizia , Stinnet, Gary, Liu, Xian-De , Ji, Baoan , Brown, Lisa V., Guha, Sushovan , Krishnan, Sunil, Halas, Naomi J. , Joshi, Amit , Biswal, Nrusingh C. , Stinnet, Gary R, Deorukhkar, Amit , Pautler, Robia G. , Joshi, Amit

Mayo Clinic

Nanomedicine | September 24, 2013 | Volume: 9 | Issue: 8 | Pages: 1209-1222

10.2217/nnm.13.84 | PMID 24063415 Get It

Shedding of Soluble Epidermal Growth Factor Receptor (sEGFR) Is Mediated by a Metalloprotease/Fibronectin/Integrin Axis and Inhibited by Cetuximab
Wilken, Jason A. , Pérez-Torres, Marianela, Nieves-Alicea, René, Cora, Elsa M., Christensen, Trace , Baron, Andre T. , Maihle, Nita J.

Mayo Clinic

Biochemistry | June 3, 2013 | Volume: 52 | Issue: 26 | Pages: 4531-4540

10.1021/bi400437d | PMID 23731208 Get It

Metabolic Effects of Oral Versus Transdermal 17β-Estradiol (E2): A Randomized Clinical Trial in Girls With Turner Syndrome
Torres‐Santiago, Lournaris , Mericq, Verónica , Taboada, Martha, Unanue, Nancy, Klein, Karen O. , Santen, Richard J. , Ross, Judith L. , Mauras, Nelly , Singh, Ravinder J. , Hossain, Jobayer

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 15, 2013 | Volume: 98 | Issue: 7 | Pages: 2716-2724

10.1210/jc.2012-4243 | PMID 23678038 Get It

Comparison of three staining methods to identify eosinophils in formalin‐fixed canine skin
Gomes, P., Torres, Sheila M. F. , Plager, Douglas A., Jessen, Carl R., Lee, James J.

Mayo Clinic

Veterinary Dermatology | April 25, 2013 | Volume: 24 | Issue: 3 | Pages: 323

10.1111/vde.12029 | PMID 23617395 Get It

BackgroundStudies comparing the ability of staining methods to detect eosinophils in formalin‐fixed canine skin are lacking.Hypothesis/ObjectivesThe aim of this study was to compare the effectiveness of eosinophil peroxidase monoclonal antibody (EPXmAb), Luna and haematoxylin and eosin (H&E) to detect eosinophils in fixed canine skin by assessing the following parameters: (i) specificity of eosinophil staining; (ii) extracellular eosinophil granule staining; (iii) tissue background staining; (iv) contrast between eosinophil and surrounding tissue staining; and (v) differences in the number of eosinophils detected by each stain.MethodsThree serial sections of formalin‐fixed, paraffin‐embedded tissues of predominantly eosinophilic skin diseases (n = 8), noneosinophilic skin diseases (n = 7) and normal canine skin (n = 1) were stained with the three stains. Each parameter was independently assessed and scored by two investigators.ResultsLuna and EPXmAb were specific in detecting eosinophils. The EPXmAb was significantly more effective than Luna (P < 0.001) and H&E (P < 0.001) in its ability to detect extracellular eosinophil granules (i.e. to detect intact and released eosinophil granules). The EPXmAb showed significantly less background staining compared with Luna (P = 0.0005). Moreover, significantly more stain contrast was noted with EPXmAb compared with Luna (P = 0.003) and H&E (P < 0.001). There was no significant difference between the mean eosinophil counts among the three stains.Conclusion and clinical importanceThe three stains were shown to be useful to detect and quantify eosinophils in fixed canine skin. The EPXmAb‐based immunohistochemical stain proved to be a novel tool to detect eosinophils in canine skin.